Guggenheim Downgrades 10X Genomics (TXG) to Neutral
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $57.19 +1.96%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Guggenheim analyst Subbu Nambi downgraded 10X Genomics (NASDAQ: TXG) from Buy to Neutral.
For an analyst ratings summary and ratings history on 10X Genomics click here. For more ratings news on 10X Genomics click here.
Shares of 10X Genomics closed at $19.88 yesterday.
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
- Kotak Downgrades LG Electronics India (LGEL:IN) to Reduce (3)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
